Press Releases

There are currently no events to display.
Date Title  
Toggle Summary OraSure Announces Sale of Cryosurgical Systems Business
BETHLEHEM, Pa. , Aug. 19, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced the sale of its cryosurgical systems business to CryoConcepts, LP for an aggregate purchase price of $12 million
Toggle Summary UPDATE – OraSure Technologies Appoints James A. Datin to Its Board of Directors
BETHLEHEM, PA , Aug. 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of James A. Datin , as a member of the Company’s Board of Directors.  Mr.
Toggle Summary Orasure Technologies Appoints James a. Datin to Its Board of Directors
BETHLEHEM, PA , Aug. 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of James A. Datin , as a member of the Company’s Board of Directors.  Mr.
Toggle Summary OraSure Announces 2019 Second Quarter Financial Results
BETHLEHEM, Pa. , Aug. 06, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its financial results for the three and six months ended June 30, 2019 .
Toggle Summary Orasure Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference
BETHLEHEM, Pa. , July 31, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang , President and CEO, will speak to the investment community at the 39 th Annual
Toggle Summary OraSure Technologies Earnings Conference Call Invitation
2019 Second Quarter Earnings Conference Call Tuesday, August 6, 2019, 5:00 p.m. ET BETHLEHEM, Pa. , July 25, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2019 second quarter financial results, updated financial
Toggle Summary OraSure Technologies and Others Join Forces for HIV Testing Day
Free HIV tests will be available across the country to spread awareness for National HIV Testing Day on June 27. BETHLEHEM, Pa. , June 26, 2019 (GLOBE NEWSWIRE) -- National HIV Testing Day will be commemorated on June 27 across the nation with efforts to raise awareness of HIV and encourage people
Toggle Summary UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference   
[Updated Release to Correct Date of Presentation] BETHLEHEM, Pa. , June 14, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Roberto Cuca, Chief Financial Officer, will speak to the
Toggle Summary Orasure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference
BETHLEHEM, Pa. , June 13, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Mr. Roberto Cuca , Chief Financial Officer, will speak to the investment community at the Raymond James Life
Toggle Summary OraSure Technologies to Present at Jefferies 2019 Healthcare Conference  
BETHLEHEM, Pa. , May 29, 2019 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced that Dr. Stephen S. Tang , President and CEO, will speak to the investment community at the Jefferies 2019